The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis—lessons from the South African experience
Drug-resistant tuberculosis (DR-TB) threatens to derail tuberculosis control efforts, particularly in Africa where the disease remains out of control. The dogma that DR-TB epidemics are fueled by unchecked rates of acquired resistance in inadequately treated or non-adherent individuals is no longer...
Saved in:
| Published in: | The Lancet infectious diseases Vol. 24; no. 9; pp. e559 - e575 |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
Elsevier Ltd
01.09.2024
Elsevier Limited |
| Subjects: | |
| ISSN: | 1473-3099, 1474-4457, 1474-4457 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Drug-resistant tuberculosis (DR-TB) threatens to derail tuberculosis control efforts, particularly in Africa where the disease remains out of control. The dogma that DR-TB epidemics are fueled by unchecked rates of acquired resistance in inadequately treated or non-adherent individuals is no longer valid in most high DR-TB burden settings, where community transmission is now widespread. A large burden of DR-TB in Africa remains undiagnosed due to inadequate access to diagnostic tools that simultaneously detect tuberculosis and screen for resistance. Furthermore, acquisition of drug resistance to new and repurposed drugs, for which diagnostic solutions are not yet available, presents a major challenge for the implementation of novel, all-oral, shortened (6–9 months) treatment. Structural challenges including poverty, stigma, and social distress disrupt engagement in care, promote poor treatment outcomes, and reduce the quality of life for people with DR-TB. We reflect on the lessons learnt from the South African experience in implementing state-of-the-art advances in diagnostic solutions, deploying recent innovations in pharmacotherapeutic approaches for rapid cure, understanding local transmission dynamics and implementing interventions to curtail DR-TB transmission, and in mitigating the catastrophic socioeconomic costs of DR-TB. We also highlight globally relevant and locally responsive research priorities for achieving DR-TB control in South Africa. |
|---|---|
| AbstractList | Drug-resistant tuberculosis (DR-TB) threatens to derail tuberculosis control efforts, particularly in Africa where the disease remains out of control. The dogma that DR-TB epidemics are fueled by unchecked rates of acquired resistance in inadequately treated or non-adherent individuals is no longer valid in most high DR-TB burden settings, where community transmission is now widespread. A large burden of DR-TB in Africa remains undiagnosed due to inadequate access to diagnostic tools that simultaneously detect tuberculosis and screen for resistance. Furthermore, acquisition of drug resistance to new and repurposed drugs, for which diagnostic solutions are not yet available, presents a major challenge for the implementation of novel, all-oral, shortened (6-9 months) treatment. Structural challenges including poverty, stigma, and social distress disrupt engagement in care, promote poor treatment outcomes, and reduce the quality of life for people with DR-TB. We reflect on the lessons learnt from the South African experience in implementing state-of-the-art advances in diagnostic solutions, deploying recent innovations in pharmacotherapeutic approaches for rapid cure, understanding local transmission dynamics and implementing interventions to curtail DR-TB transmission, and in mitigating the catastrophic socioeconomic costs of DR-TB. We also highlight globally relevant and locally responsive research priorities for achieving DR-TB control in South Africa.Drug-resistant tuberculosis (DR-TB) threatens to derail tuberculosis control efforts, particularly in Africa where the disease remains out of control. The dogma that DR-TB epidemics are fueled by unchecked rates of acquired resistance in inadequately treated or non-adherent individuals is no longer valid in most high DR-TB burden settings, where community transmission is now widespread. A large burden of DR-TB in Africa remains undiagnosed due to inadequate access to diagnostic tools that simultaneously detect tuberculosis and screen for resistance. Furthermore, acquisition of drug resistance to new and repurposed drugs, for which diagnostic solutions are not yet available, presents a major challenge for the implementation of novel, all-oral, shortened (6-9 months) treatment. Structural challenges including poverty, stigma, and social distress disrupt engagement in care, promote poor treatment outcomes, and reduce the quality of life for people with DR-TB. We reflect on the lessons learnt from the South African experience in implementing state-of-the-art advances in diagnostic solutions, deploying recent innovations in pharmacotherapeutic approaches for rapid cure, understanding local transmission dynamics and implementing interventions to curtail DR-TB transmission, and in mitigating the catastrophic socioeconomic costs of DR-TB. We also highlight globally relevant and locally responsive research priorities for achieving DR-TB control in South Africa. Drug-resistant tuberculosis (DR-TB) threatens to derail tuberculosis control efforts, particularly in Africa where the disease remains out of control. The dogma that DR-TB epidemics are fueled by unchecked rates of acquired resistance in inadequately treated or non-adherent individuals is no longer valid in most high DR-TB burden settings, where community transmission is now widespread. A large burden of DR-TB in Africa remains undiagnosed due to inadequate access to diagnostic tools that simultaneously detect tuberculosis and screen for resistance. Furthermore, acquisition of drug resistance to new and repurposed drugs, for which diagnostic solutions are not yet available, presents a major challenge for the implementation of novel, all-oral, shortened (6-9 months) treatment. Structural challenges including poverty, stigma, and social distress disrupt engagement in care, promote poor treatment outcomes, and reduce the quality of life for people with DR-TB. We reflect on the lessons learnt from the South African experience in implementing state-of-the-art advances in diagnostic solutions, deploying recent innovations in pharmacotherapeutic approaches for rapid cure, understanding local transmission dynamics and implementing interventions to curtail DR-TB transmission, and in mitigating the catastrophic socioeconomic costs of DR-TB. We also highlight globally relevant and locally responsive research priorities for achieving DR-TB control in South Africa. Summary Drug-resistant tuberculosis (DR-TB) threatens to derail tuberculosis control efforts, particularly in Africa where the disease remains out of control. The dogma that DR-TB epidemics are fueled by unchecked rates of acquired resistance in inadequately treated or non-adherent individuals is no longer valid in most high DR-TB burden settings, where community transmission is now widespread. A large burden of DR-TB in Africa remains undiagnosed due to inadequate access to diagnostic tools that simultaneously detect tuberculosis and screen for resistance. Furthermore, acquisition of drug resistance to new and repurposed drugs, for which diagnostic solutions are not yet available, presents a major challenge for the implementation of novel, all-oral, shortened (6–9 months) treatment. Structural challenges including poverty, stigma, and social distress disrupt engagement in care, promote poor treatment outcomes, and reduce the quality of life for people with DR-TB. We reflect on the lessons learnt from the South African experience in implementing state-of-the-art advances in diagnostic solutions, deploying recent innovations in pharmacotherapeutic approaches for rapid cure, understanding local transmission dynamics and implementing interventions to curtail DR-TB transmission, and in mitigating the catastrophic socioeconomic costs of DR-TB. We also highlight globally relevant and locally responsive research priorities for achieving DR-TB control in South Africa. |
| Author | Ndjeka, Norbert Loveday, Marian Omar, Shaheed Vally Daftary, Amrita Naidoo, Kogieleum Mathema, Barun O'Donnell, Max Perumal, Rubeshan Georghiou, Sophia B Cox, Helen Ismail, Nazir |
| Author_xml | – sequence: 1 givenname: Kogieleum surname: Naidoo fullname: Naidoo, Kogieleum email: kogie.naidoo@caprisa.org organization: SAMRC-CAPRISA HIV/TB Pathogenesis and Treatment Research Unit, Centre for the AIDS Programme of Research in South Africa, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa – sequence: 2 givenname: Rubeshan surname: Perumal fullname: Perumal, Rubeshan organization: SAMRC-CAPRISA HIV/TB Pathogenesis and Treatment Research Unit, Centre for the AIDS Programme of Research in South Africa, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa – sequence: 3 givenname: Helen surname: Cox fullname: Cox, Helen organization: Institute of Infectious Diseases and Molecular Medicine, Wellcome Centre for Infectious Disease Research and Division of Medical Microbiology, University of Cape Town, Cape Town, South Africa – sequence: 4 givenname: Barun surname: Mathema fullname: Mathema, Barun organization: Mailman School of Public Health, Columbia University, New York City, NY, USA – sequence: 5 givenname: Marian surname: Loveday fullname: Loveday, Marian organization: South African Medical Research Council, Durban, South Africa – sequence: 6 givenname: Nazir surname: Ismail fullname: Ismail, Nazir organization: School of Pathology, University of Witwatersrand, Johannesburg, South Africa – sequence: 7 givenname: Shaheed Vally surname: Omar fullname: Omar, Shaheed Vally organization: Centre for Tuberculosis, National & WHO Supranational TB Reference Laboratory, National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Johannesburg, South Africa – sequence: 8 givenname: Sophia B surname: Georghiou fullname: Georghiou, Sophia B organization: FIND, Geneva, Switzerland – sequence: 9 givenname: Amrita surname: Daftary fullname: Daftary, Amrita organization: SAMRC-CAPRISA HIV/TB Pathogenesis and Treatment Research Unit, Centre for the AIDS Programme of Research in South Africa, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa – sequence: 10 givenname: Max surname: O'Donnell fullname: O'Donnell, Max organization: SAMRC-CAPRISA HIV/TB Pathogenesis and Treatment Research Unit, Centre for the AIDS Programme of Research in South Africa, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa – sequence: 11 givenname: Norbert surname: Ndjeka fullname: Ndjeka, Norbert organization: TB Control and Management, Republic of South Africa National Department of Health, Pretoria, South Africa |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38527475$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkc1u1DAUhS3Uiv7AI4AssSnSBOzEiRMhhKqqUKRKLFrWln9upi6JPbUdxOxY8Ag8IU9SZ6awmE1Z2bK_c3x9zhHac94BQi8oeUMJbd5eUcaroiJdd1Ky14RQxgryBB3mY1YwVvO9zX6LHKCjGG8zxClhT9FB1dYlZ7w-RL-ubwDDyhoYrR_8cr3AKUgXRxuj9W6BjZVL56ONCyydwaN0cgkjuIR9j02YlkWAfJtkPkmTgqCnYcb__Pw9QIzeRdwHP-KU37nyU7rBp32wWjoMP1YQLDgNz9B-L4cIzx_WY_T14_n12UVx-eXT57PTy0IzxlNRtlypzoCpGm2kUb0CVTWmM5R2TNG21KWkuimJlFqRsi3b3vStVhR4owkn1TE62fqugr-bICaRv6lhGKQDP0WRo2rqum14k9FXO-itn4LL081UXXUtoXWmXj5QkxrBiFWwowxr8TffDNRbQAcfY4D-H0KJmHsUmx5nz06UTGx6FPOk73Z02iaZciO5HTs8qv6wVUMO87uFIKLeBG1sAJ2E8fZRh_c7DnqwLtc2fIP1f-jvAYLyzaY |
| CitedBy_id | crossref_primary_10_1080_22221751_2025_2521842 crossref_primary_10_1016_j_jinf_2025_106517 crossref_primary_10_1097_INF_0000000000004933 crossref_primary_10_1093_cid_ciaf313 crossref_primary_10_36303_SAGP_1204 crossref_primary_10_1128_spectrum_02181_24 crossref_primary_10_4103_ajim_ajim_30_25 crossref_primary_10_1016_j_ebiom_2025_105685 crossref_primary_10_1016_j_bmcl_2024_129846 crossref_primary_10_1016_j_actatropica_2025_107748 crossref_primary_10_1186_s12906_025_05002_w |
| Cites_doi | 10.1016/S2666-5247(23)00317-8 10.1080/17441692.2014.934266 10.1093/jac/dkaa136 10.1128/JCM.05832-11 10.1038/s41591-021-01358-x 10.5588/ijtld.15.0341 10.1016/j.ijid.2014.12.045 10.1016/S2666-5247(22)00359-7 10.1016/S0029-7844(00)00857-7 10.1038/ng.3767 10.1371/journal.pgph.0002283 10.1007/s11904-022-00641-x 10.5588/ijtld.16.0584 10.1371/journal.pgph.0001357 10.1183/13993003.00312-2019 10.1093/jinfdis/jiq064 10.1016/j.meegid.2011.07.019 10.1056/NEJMoa1604544 10.1016/S2214-109X(20)30548-9 10.1016/S2666-5247(20)30031-8 10.1371/journal.pone.0200632 10.1016/j.ijid.2014.12.014 10.1093/infdis/jix354 10.1016/S1473-3099(07)70108-1 10.1038/ncomms8119 10.1093/cid/cix851 10.5588/pha.21.0007 10.5588/ijtld.11.0401 10.1016/S2214-109X(23)00324-8 10.1128/JCM.02057-18 10.1186/s12991-020-00281-8 10.1016/j.eclinm.2023.101900 10.1016/S1473-3099(22)00149-9 10.1016/S2214-109X(21)00299-0 10.1186/s13073-020-00793-8 10.1056/NEJMoa1901814 10.1038/ng.2878 10.1186/s12879-018-3080-2 10.2989/16085906.2023.2213213 10.1016/S1473-3099(21)00470-9 10.1038/ejcn.2014.40 10.1186/s12889-021-10267-0 10.1016/j.ijid.2022.03.005 10.1111/j.1469-0691.2004.00758.x 10.1056/NEJMoa2117166 10.1016/S0140-6736(23)01231-X 10.1093/cid/ciaa189 10.1183/13993003.01030-2018 10.1183/23120541.00182-2023 10.1073/pnas.1906636116 10.1186/s12916-019-1487-2 10.7196/SAMJnew.7803 10.1093/cid/ciz074 10.1016/S2214-109X(23)00539-9 10.1016/S2666-5247(23)00172-6 10.1093/cid/ciaa1557 10.1016/S1473-3099(16)30418-2 10.1097/QAI.0000000000002940 10.5588/ijtld.17.0448 10.1186/s41182-020-00221-y 10.4269/ajtmh.19-0426 10.1007/s13318-020-00657-x 10.5588/ijtld.15.0360 10.1128/JCM.01771-16 10.1183/13993003.00639-2023 10.1016/S1473-3099(19)30309-3 10.1183/13993003.00246-2018 10.3201/eid2003.131083 10.1128/mBio.00812-17 10.1371/journal.pone.0185105 10.1097/INF.0000000000003069 10.1056/NEJMc1505196 10.1038/s41467-023-41937-9 10.5588/ijtld.22.0514 10.1136/bmjgh-2023-012666 10.1186/s12916-016-0566-x 10.1093/cid/cis732 10.1183/13993003.00621-2021 10.1111/bcp.13432 10.7554/eLife.38200 10.2471/BLT.19.243584 10.1371/journal.pgph.0000312 10.1038/nrd4001 10.1016/S1473-3099(18)30496-1 10.5588/ijtld.14.0242 10.1097/QAD.0000000000000802 10.1371/journal.pone.0147397 10.1186/s12960-021-00565-4 10.1016/S2213-2600(17)30079-6 10.1056/NEJMc2103049 10.1056/NEJMoa2119430 10.1186/s12889-019-8035-z 10.1016/S1473-3099(15)70058-7 10.1016/S1473-3099(23)00498-X 10.1016/S0140-6736(06)69573-1 10.1186/s13063-023-07520-9 10.1183/13993003.01596-2017 10.1371/journal.pmed.1002882 10.1054/tuld.1998.0002 10.1183/16000617.0221-2022 10.1111/1471-0528.14408 10.1371/journal.pmed.1001880 |
| ContentType | Journal Article |
| Copyright | 2024 Elsevier Ltd Copyright © 2024 Elsevier Ltd. All rights reserved. 2024. Elsevier Ltd |
| Copyright_xml | – notice: 2024 Elsevier Ltd – notice: Copyright © 2024 Elsevier Ltd. All rights reserved. – notice: 2024. Elsevier Ltd |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7RV 7U9 7X7 7XB 88E 8AO 8C1 8C2 8FI 8FJ 8FK ABUWG AEUYN AFKRA BENPR C1K CCPQU FYUFA GHDGH H94 K9. KB0 M0S M1P M7N NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
| DOI | 10.1016/S1473-3099(24)00144-0 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Nursing & Allied Health Database Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Lancet Titles Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) One Sustainability ProQuest Central UK/Ireland ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Nursing & Allied Health Premium Proquest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) Lancet Titles ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest One Academic Middle East (New) |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7RV name: Nursing & Allied Health Database url: https://search.proquest.com/nahs sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1474-4457 |
| EndPage | e575 |
| ExternalDocumentID | 38527475 10_1016_S1473_3099_24_00144_0 S1473309924001440 |
| Genre | Journal Article Review |
| GeographicLocations | South Africa Mozambique Africa |
| GeographicLocations_xml | – name: South Africa – name: Africa – name: Mozambique |
| GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R01 AI167795 |
| GroupedDBID | --- --K --M -RU ..I .1- .FO 0R~ 123 1B1 1P~ 1~5 29L 4.4 457 4G. 53G 5VS 6PF 7-5 71M 7RV 7X7 88E 8AO 8C1 8C2 8FI 8FJ AAAJQ AAEDT AAEDW AAIKJ AAKOC AALRI AAMRU AAQFI AAQQT AAQXK AARKO AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABJNI ABMAC ABMZM ABUWG ABWVN ACGFS ACIEU ACLOT ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADMUD ADNMO AEIPS AEKER AENEX AEUPX AEUYN AEVXI AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGEKW AGHFR AGQPQ AHMBA AIGII AIIUN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BENPR BKEYQ BKOJK BNPGV BPHCQ BVXVI CCPQU CJTIS CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-Q GBLVA HF~ HMCUK HVGLF HZ~ IHE J1W KOM M1P M41 MO0 N9A NAPCQ O-L O9- OD- OO. OZT P-8 P-9 P2P PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO R2- ROL RPZ SDG SEL SES SPCBC SSH SSI SSZ T5K TLN UKHRP UV1 WOW XBR Z5R ~HD 3V. AACTN AAYOK AFCTW AFKWA AJOXV ALIPV AMFUW RIG SDF 9DU AAYXX AFFHD CITATION AGCQF AGRNS CGR CUY CVF ECM EIF NPM 7QL 7U9 7XB 8FK C1K H94 K9. M7N PKEHL PQEST PQUKI PRINS 7X8 PUEGO |
| ID | FETCH-LOGICAL-c447t-287bb9ded36cdadbfbeb36d9d1194b182c2a1c620aacb02828fdf8cb1e76c0703 |
| IEDL.DBID | 8C1 |
| ISICitedReferencesCount | 14 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001306456200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1473-3099 1474-4457 |
| IngestDate | Sun Sep 28 11:45:03 EDT 2025 Tue Oct 07 05:27:15 EDT 2025 Mon Jul 21 05:51:18 EDT 2025 Tue Nov 18 21:29:37 EST 2025 Sat Nov 29 01:52:10 EST 2025 Sat Dec 28 15:49:39 EST 2024 Tue Oct 14 19:30:40 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Language | English |
| License | Copyright © 2024 Elsevier Ltd. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c447t-287bb9ded36cdadbfbeb36d9d1194b182c2a1c620aacb02828fdf8cb1e76c0703 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| PMID | 38527475 |
| PQID | 3095398015 |
| PQPubID | 44001 |
| ParticipantIDs | proquest_miscellaneous_3096558676 proquest_journals_3095398015 pubmed_primary_38527475 crossref_primary_10_1016_S1473_3099_24_00144_0 crossref_citationtrail_10_1016_S1473_3099_24_00144_0 elsevier_sciencedirect_doi_10_1016_S1473_3099_24_00144_0 elsevier_clinicalkey_doi_10_1016_S1473_3099_24_00144_0 |
| PublicationCentury | 2000 |
| PublicationDate | September 2024 2024-09-00 2024-Sep 20240901 |
| PublicationDateYYYYMMDD | 2024-09-01 |
| PublicationDate_xml | – month: 09 year: 2024 text: September 2024 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: London |
| PublicationTitle | The Lancet infectious diseases |
| PublicationTitleAlternate | Lancet Infect Dis |
| PublicationYear | 2024 |
| Publisher | Elsevier Ltd Elsevier Limited |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited |
| References | Joseph L, Ismail F, Ismail NA, Omar SV. Prevalence of linezolid resistance and associated mutations amongst pre-XDR and XDR isolates requiring drug susceptibility testing at the South African National TB Reference Laboratory. Hyderabad, India: 50th Union World Conference on Lung Health, 2019. (bib14) 2023 Loveday, Wallengren, Voce (bib116) 2012; 16 Aaron, Saadoun, Calatroni (bib59) 2004; 10 Mathema, Andrews, Cohen (bib28) 2017; 216 Hatherell, Colijn, Stagg, Jackson, Winter, Abubakar (bib26) 2016; 14 Mathad, Gupta (bib83) 2012; 55 Shete, Kadota, Nanyunja (bib123) 2023; 9 Miiro, Olum, Baluku (bib81) 2023; 33 (bib17) 2022 Akalu, Clements, Wolde, Alene (bib133) 2023; 57 Garcia-Basteiro, Hurtado, Castillo (bib12) 2019; 54 (bib64) 2022 (bib74) 2023 Oostvogels, Ley, Heupink (bib34) 2022; 8 Casali, Nikolayevskyy, Balabanova (bib19) 2014; 46 Sobhy, Babiker, Zamora, Khan, Kunst (bib86) 2017; 124 Norton, Moll, Madi (bib127) 2023; 22 Daftary, Padayatchi, O'Donnell (bib108) 2014; 9 Chakravorty, Simmons, Rowneki (bib51) 2017; 8 (bib54) 2023 Murphy, Kgowedi, Coetzee (bib7) 2022; 2 Polsfuss, Hofmann-Thiel, Merker (bib48) 2019; 69 (bib111) 2019 Loveday, Hughes, Sunkari (bib94) 2021; 72 Law, Daftary, O'Donnell, Padayatchi, Calzavara, Menzies (bib121) 2019; 53 Bhargava, Bhargava, Meher (bib125) 2023; 11 Nuwagira, Stadelman, Baluku (bib131) 2020; 48 (bib4) 2022 Yang, Luo, Shen (bib29) 2017; 17 Beckert, Sanchez-Padilla, Merker (bib45) 2020; 12 MacLean, Sulis, Denkinger, Johnston, Pai, Ahmad Khan (bib60) 2019; 57 Cevik M, Eristavi M, Variava E, et al. SimpliciTB results and hepatic safety of pretomanid regimens +/- pyrazinamide. Seattle, WA, USA: Conference on retroviruses and oportunistic infections, 2023. Liboon Aranas, Alam, Gyawali, Alam (bib110) 2023; 60 Gagneux, Small (bib30) 2007; 7 Gupta, Bhosale, Kinikar (bib88) 2011; 203 Shah, Auld, Brust (bib24) 2017; 376 Nyang'wa, Berry, Kazounis (bib79) 2022; 387 Chihota, Müller, Mlambo (bib31) 2012; 50 Bloemberg, Keller, Stucki (bib46) 2015; 373 Cannon, Oladimeji, Goon (bib106) 2021; 21 Timm, Bateson, Solanki (bib66) 2023; 3 (bib134) 2016 Ivanova, Hoffmann, Lange, Hoelscher, Rachow (bib132) 2023; 32 Silva, Arinaminpathy, Atun, Goosby, Reid (bib5) 2021; 9 Conradie, Bagdasaryan, Borisov (bib78) 2022; 387 Mucheleng'anga, Himwaze, Telendiy (bib11) 2022; 124 Bates, Ahmed, Kapata, Maeurer, Mwaba, Zumla (bib82) 2015; 32 Gupta, Hughes, Garcia-Prats, McIntire, Hesseling (bib89) 2019; 16 Dheda, Gumbo, Maartens (bib6) 2017; 5 (bib115) 2015 Salazar-Austin, Hoffmann, Cohn (bib85) 2018; 66 McNabb, Bergman, Farley (bib101) 2021; 11 Ismail, Omar, Moultrie (bib42) 2022; 22 Brown, Capocci, Smith, Morris, Abubakar, Lipman (bib103) 2015; 32 Moyo, Ismail, Van der Walt (bib8) 2022; 22 Nimmo, Millard, van Dorp (bib43) 2020; 1 Daftary, Mondal, Zelnick (bib102) 2021; 9 (bib55) 2016 Thomas, Buch, Pillay (bib128) 2021; 19 Yoshino, Sidney-Annerstedt, Wingfield (bib122) 2023; 3 Cohen, Abeel, Manson McGuire (bib20) 2015; 12 Menzies, Allwood, Dean (bib15) 2023; 14 Myburgh, Baloyi, Loveday (bib118) 2023; 3 Gandhi, Moll, Sturm (bib38) 2006; 368 (bib49) 2021 Chesov, Chesov, Maurer (bib47) 2022; 59 (bib13) 2023 Ajudua, Mash (bib126) 2022; 64 (bib53) 2021 Romanowski, Baumann, Basham, Ahmad Khan, Fox, Johnston (bib130) 2019; 19 Brown, Challagundla, Baugh (bib18) 2019; 116 O'Donnell, Daftary, Frick (bib117) 2016; 20 Ismail, Nathanson, Zignol, Kasaeva (bib73) 2023; 8 Conradie F, Phillips P, Badat T, et al. High rate of successful outcomes treating RR-TB with a delamanid-bedaquiline regimen in BEAT Tuberculosis: an interim analysis. Union World Conference on Lung Health, 2022. (bib99) June 6, 2019 Zumla, Nahid, Cole (bib76) 2013; 12 Shiu, Min, Kiang (bib93) 2021; 46 Ramma, Cox, Wilkinson (bib105) 2015; 19 O'Donnell, Padayatchi, Wolf (bib137) 2022; 90 Sartorius, Gray, Davis Weaver (bib140) 2024; 12 Kadura, King, Nakhoul (bib68) 2020; 75 Merker, Barbier, Cox (bib37) 2018; 7 Eldholm, Monteserin, Rieux (bib21) 2015; 6 Ahmed S. Treament of children and adolescents using bedquiline and delaminid: results from the endTB study (OA24–764–21). Union World Conference on Lung Health, 2022. Naidu, Pillay, Ramlall (bib112) 2020; 103 Ngwatu, Nsengiyumva, Oxlade (bib139) 2018; 51 Derendinger, Dippenaar, de Vos (bib65) 2023; 4 Gandhi, Brust, Moodley (bib35) 2014; 20 Chihota, Niehaus, Streicher (bib32) 2018; 13 Barilar, Fernando, Utpatel (bib41) 2024; 24 Nimmo, Bionghi, Cummings (bib71) 2024; 5 (bib40) 2018 Conradie, Diacon, Ngubane (bib77) 2020; 382 Nelson, Shah, Mathema (bib39) 2018; 218 Jones, Mathad, Dooley, Eke (bib87) 2022; 19 Widen, Gallagher (bib91) 2014; 68 Chakravorty, Roh, Glass (bib52) 2016; 55 Mohr, Hughes, Snyman (bib120) 2015; 105 (bib58) 2023 Ross, Perumal, Wolf (bib135) 2023; 24 Schalkwijk, Greupink, Burger (bib92) 2017; 83 Gygli, Loiseau, Jugheli (bib36) 2021; 27 (bib63) 2023 Manson, Cohen, Abeel (bib27) 2017; 49 Gupta, Lucas, Fielding, Lawn (bib10) 2015; 29 Hoger, Lykens, Beavers, Katz, Miller (bib129) 2014; 18 (bib75) 2022 (bib95) 2022 Perumal, Bionghi, Nimmo (bib67) 2023; 62 Zelnick, Daftary, Hwang (bib136) 2021; 73 Sweetland, Kritski, Oquendo (bib114) 2017; 21 Furin, Loveday, Hlangu (bib109) 2020; 20 Thomas, Shanmugam, Malaisamy (bib100) 2016; 11 Acquah, Mohr-Holland, Daniels (bib96) 2021; 40 (bib62) 2020 Musa, Adamu, Galadanci, Zubayr, Odoh, Aliyu (bib16) 2017; 12 (bib72) 2023 (bib119) 2019 (bib1) 2023 Huston Presley, Wong, Roman, Amini, Catalano (bib90) 2000; 96 Omar, Ismail, Ndjeka, Kaniga, Ismail (bib69) 2022; 386 (bib61) 2020 Nightingale, Carlin, Meghji (bib104) 2023; 27 (bib56) 2022 (bib57) 2016 Streicher, Muller, Chihota (bib23) 2012; 12 Odayar, Rangaka, Zerbe (bib84) 2018; 22 Klopper, Heupink, Hill-Cawthorne (bib33) 2020; 18 (bib2) 2022 Madan, Rosu, Tefera (bib107) 2020; 98 Duko, Bedaso, Ayano (bib113) 2020; 19 Bionghi, Daftary, Maharaj (bib138) 2018; 18 Makhado, Matabane, Faccin (bib44) 2018; 18 Bates, Mudenda, Shibemba (bib9) 2015; 15 Auld, Shah, Mathema (bib25) 2018; 52 Bhargava, Bhargava, Meher (bib124) 2023; 402 Bagcchi (bib3) 2023; 4 Ramaswamy, Musser (bib22) 1998; 79 (bib50) 2023 Duko (10.1016/S1473-3099(24)00144-0_bib113) 2020; 19 Barilar (10.1016/S1473-3099(24)00144-0_bib41) 2024; 24 Sartorius (10.1016/S1473-3099(24)00144-0_bib140) 2024; 12 Nimmo (10.1016/S1473-3099(24)00144-0_bib71) 2024; 5 Kadura (10.1016/S1473-3099(24)00144-0_bib68) 2020; 75 Ismail (10.1016/S1473-3099(24)00144-0_bib73) 2023; 8 (10.1016/S1473-3099(24)00144-0_bib115) 2015 Acquah (10.1016/S1473-3099(24)00144-0_bib96) 2021; 40 Ismail (10.1016/S1473-3099(24)00144-0_bib42) 2022; 22 Daftary (10.1016/S1473-3099(24)00144-0_bib108) 2014; 9 Sweetland (10.1016/S1473-3099(24)00144-0_bib114) 2017; 21 Hatherell (10.1016/S1473-3099(24)00144-0_bib26) 2016; 14 Cohen (10.1016/S1473-3099(24)00144-0_bib20) 2015; 12 Liboon Aranas (10.1016/S1473-3099(24)00144-0_bib110) 2023; 60 10.1016/S1473-3099(24)00144-0_bib70 Beckert (10.1016/S1473-3099(24)00144-0_bib45) 2020; 12 (10.1016/S1473-3099(24)00144-0_bib58) 2023 Shiu (10.1016/S1473-3099(24)00144-0_bib93) 2021; 46 (10.1016/S1473-3099(24)00144-0_bib63) 2023 Nuwagira (10.1016/S1473-3099(24)00144-0_bib131) 2020; 48 Streicher (10.1016/S1473-3099(24)00144-0_bib23) 2012; 12 Loveday (10.1016/S1473-3099(24)00144-0_bib116) 2012; 16 Gandhi (10.1016/S1473-3099(24)00144-0_bib35) 2014; 20 (10.1016/S1473-3099(24)00144-0_bib75) 2022 Sobhy (10.1016/S1473-3099(24)00144-0_bib86) 2017; 124 (10.1016/S1473-3099(24)00144-0_bib95) 2022 Ramaswamy (10.1016/S1473-3099(24)00144-0_bib22) 1998; 79 Mathad (10.1016/S1473-3099(24)00144-0_bib83) 2012; 55 Brown (10.1016/S1473-3099(24)00144-0_bib103) 2015; 32 10.1016/S1473-3099(24)00144-0_bib80 Bhargava (10.1016/S1473-3099(24)00144-0_bib125) 2023; 11 Chakravorty (10.1016/S1473-3099(24)00144-0_bib52) 2016; 55 Makhado (10.1016/S1473-3099(24)00144-0_bib44) 2018; 18 Omar (10.1016/S1473-3099(24)00144-0_bib69) 2022; 386 Eldholm (10.1016/S1473-3099(24)00144-0_bib21) 2015; 6 (10.1016/S1473-3099(24)00144-0_bib72) 2023 Chihota (10.1016/S1473-3099(24)00144-0_bib32) 2018; 13 10.1016/S1473-3099(24)00144-0_bib98 Bionghi (10.1016/S1473-3099(24)00144-0_bib138) 2018; 18 10.1016/S1473-3099(24)00144-0_bib97 Chakravorty (10.1016/S1473-3099(24)00144-0_bib51) 2017; 8 Bates (10.1016/S1473-3099(24)00144-0_bib9) 2015; 15 MacLean (10.1016/S1473-3099(24)00144-0_bib60) 2019; 57 Huston Presley (10.1016/S1473-3099(24)00144-0_bib90) 2000; 96 Law (10.1016/S1473-3099(24)00144-0_bib121) 2019; 53 (10.1016/S1473-3099(24)00144-0_bib61) 2020 Ivanova (10.1016/S1473-3099(24)00144-0_bib132) 2023; 32 Bloemberg (10.1016/S1473-3099(24)00144-0_bib46) 2015; 373 (10.1016/S1473-3099(24)00144-0_bib56) 2022 Daftary (10.1016/S1473-3099(24)00144-0_bib102) 2021; 9 Klopper (10.1016/S1473-3099(24)00144-0_bib33) 2020; 18 Jones (10.1016/S1473-3099(24)00144-0_bib87) 2022; 19 Bhargava (10.1016/S1473-3099(24)00144-0_bib124) 2023; 402 (10.1016/S1473-3099(24)00144-0_bib57) 2016 Gandhi (10.1016/S1473-3099(24)00144-0_bib38) 2006; 368 (10.1016/S1473-3099(24)00144-0_bib50) 2023 Shete (10.1016/S1473-3099(24)00144-0_bib123) 2023; 9 (10.1016/S1473-3099(24)00144-0_bib14) 2023 Furin (10.1016/S1473-3099(24)00144-0_bib109) 2020; 20 Timm (10.1016/S1473-3099(24)00144-0_bib66) 2023; 3 Ngwatu (10.1016/S1473-3099(24)00144-0_bib139) 2018; 51 Madan (10.1016/S1473-3099(24)00144-0_bib107) 2020; 98 O'Donnell (10.1016/S1473-3099(24)00144-0_bib117) 2016; 20 (10.1016/S1473-3099(24)00144-0_bib119) 2019 (10.1016/S1473-3099(24)00144-0_bib17) 2022 Moyo (10.1016/S1473-3099(24)00144-0_bib8) 2022; 22 Musa (10.1016/S1473-3099(24)00144-0_bib16) 2017; 12 Akalu (10.1016/S1473-3099(24)00144-0_bib133) 2023; 57 Derendinger (10.1016/S1473-3099(24)00144-0_bib65) 2023; 4 (10.1016/S1473-3099(24)00144-0_bib54) 2023 Brown (10.1016/S1473-3099(24)00144-0_bib18) 2019; 116 (10.1016/S1473-3099(24)00144-0_bib64) 2022 McNabb (10.1016/S1473-3099(24)00144-0_bib101) 2021; 11 Polsfuss (10.1016/S1473-3099(24)00144-0_bib48) 2019; 69 (10.1016/S1473-3099(24)00144-0_bib74) 2023 Zumla (10.1016/S1473-3099(24)00144-0_bib76) 2013; 12 Menzies (10.1016/S1473-3099(24)00144-0_bib15) 2023; 14 Nimmo (10.1016/S1473-3099(24)00144-0_bib43) 2020; 1 Manson (10.1016/S1473-3099(24)00144-0_bib27) 2017; 49 Casali (10.1016/S1473-3099(24)00144-0_bib19) 2014; 46 Conradie (10.1016/S1473-3099(24)00144-0_bib78) 2022; 387 Bates (10.1016/S1473-3099(24)00144-0_bib82) 2015; 32 (10.1016/S1473-3099(24)00144-0_bib4) 2022 Aaron (10.1016/S1473-3099(24)00144-0_bib59) 2004; 10 Nyang'wa (10.1016/S1473-3099(24)00144-0_bib79) 2022; 387 Nelson (10.1016/S1473-3099(24)00144-0_bib39) 2018; 218 Thomas (10.1016/S1473-3099(24)00144-0_bib128) 2021; 19 Gupta (10.1016/S1473-3099(24)00144-0_bib89) 2019; 16 Cannon (10.1016/S1473-3099(24)00144-0_bib106) 2021; 21 Schalkwijk (10.1016/S1473-3099(24)00144-0_bib92) 2017; 83 Ajudua (10.1016/S1473-3099(24)00144-0_bib126) 2022; 64 Shah (10.1016/S1473-3099(24)00144-0_bib24) 2017; 376 Chesov (10.1016/S1473-3099(24)00144-0_bib47) 2022; 59 Miiro (10.1016/S1473-3099(24)00144-0_bib81) 2023; 33 Perumal (10.1016/S1473-3099(24)00144-0_bib67) 2023; 62 Yoshino (10.1016/S1473-3099(24)00144-0_bib122) 2023; 3 Mohr (10.1016/S1473-3099(24)00144-0_bib120) 2015; 105 Odayar (10.1016/S1473-3099(24)00144-0_bib84) 2018; 22 Nightingale (10.1016/S1473-3099(24)00144-0_bib104) 2023; 27 Yang (10.1016/S1473-3099(24)00144-0_bib29) 2017; 17 Hoger (10.1016/S1473-3099(24)00144-0_bib129) 2014; 18 Chihota (10.1016/S1473-3099(24)00144-0_bib31) 2012; 50 Mucheleng'anga (10.1016/S1473-3099(24)00144-0_bib11) 2022; 124 Oostvogels (10.1016/S1473-3099(24)00144-0_bib34) 2022; 8 Merker (10.1016/S1473-3099(24)00144-0_bib37) 2018; 7 Conradie (10.1016/S1473-3099(24)00144-0_bib77) 2020; 382 Bagcchi (10.1016/S1473-3099(24)00144-0_bib3) 2023; 4 Murphy (10.1016/S1473-3099(24)00144-0_bib7) 2022; 2 (10.1016/S1473-3099(24)00144-0_bib1) 2023 (10.1016/S1473-3099(24)00144-0_bib55) 2016 Salazar-Austin (10.1016/S1473-3099(24)00144-0_bib85) 2018; 66 Loveday (10.1016/S1473-3099(24)00144-0_bib94) 2021; 72 O'Donnell (10.1016/S1473-3099(24)00144-0_bib137) 2022; 90 Naidu (10.1016/S1473-3099(24)00144-0_bib112) 2020; 103 Zelnick (10.1016/S1473-3099(24)00144-0_bib136) 2021; 73 Ramma (10.1016/S1473-3099(24)00144-0_bib105) 2015; 19 Gygli (10.1016/S1473-3099(24)00144-0_bib36) 2021; 27 (10.1016/S1473-3099(24)00144-0_bib49) 2021 Thomas (10.1016/S1473-3099(24)00144-0_bib100) 2016; 11 Garcia-Basteiro (10.1016/S1473-3099(24)00144-0_bib12) 2019; 54 Widen (10.1016/S1473-3099(24)00144-0_bib91) 2014; 68 Dheda (10.1016/S1473-3099(24)00144-0_bib6) 2017; 5 (10.1016/S1473-3099(24)00144-0_bib13) 2023 Mathema (10.1016/S1473-3099(24)00144-0_bib28) 2017; 216 Auld (10.1016/S1473-3099(24)00144-0_bib25) 2018; 52 (10.1016/S1473-3099(24)00144-0_bib53) 2021 Gupta (10.1016/S1473-3099(24)00144-0_bib10) 2015; 29 Romanowski (10.1016/S1473-3099(24)00144-0_bib130) 2019; 19 Myburgh (10.1016/S1473-3099(24)00144-0_bib118) 2023; 3 Ross (10.1016/S1473-3099(24)00144-0_bib135) 2023; 24 Norton (10.1016/S1473-3099(24)00144-0_bib127) 2023; 22 Silva (10.1016/S1473-3099(24)00144-0_bib5) 2021; 9 Gupta (10.1016/S1473-3099(24)00144-0_bib88) 2011; 203 (10.1016/S1473-3099(24)00144-0_bib2) 2022 Gagneux (10.1016/S1473-3099(24)00144-0_bib30) 2007; 7 |
| References_xml | – year: 2022 ident: bib2 article-title: Global Tuberculosis Report 2022 – volume: 62 year: 2023 ident: bib67 article-title: Baseline and treatment-emergent bedaquiline resistance in drug-resistant tuberculosis: a systematic review and meta-analysis publication-title: Eur Respir J – volume: 57 start-page: e02057 year: 2019 end-page: e02118 ident: bib60 article-title: Diagnostic accuracy of Stool Xpert MTB/RIF for detection of pulmonary tuberculosis in children: a systematic review and meta-analysis publication-title: J Clin Microbiol – volume: 32 year: 2023 ident: bib132 article-title: Post-tuberculosis lung impairment: systematic review and meta-analysis of spirometry data from 14 621 people publication-title: Eur Respir Rev – volume: 49 start-page: 395 year: 2017 end-page: 402 ident: bib27 article-title: Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance publication-title: Nat Genet – volume: 17 start-page: 275 year: 2017 end-page: 284 ident: bib29 article-title: Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation publication-title: Lancet Infect Dis – volume: 7 start-page: 7 year: 2018 ident: bib37 article-title: Compensatory evolution drives multidrug-resistant tuberculosis in Central Asia publication-title: eLife – volume: 40 start-page: e191 year: 2021 end-page: e192 ident: bib96 article-title: Outcomes of children born to pregnant women with drug-resistant tuberculosis treated with novel drugs in Khayelitsha, South Africa: a report of five patients publication-title: Pediatr Infect Dis J – volume: 18 start-page: 171 year: 2018 ident: bib138 article-title: Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa publication-title: BMC Infect Dis – volume: 52 year: 2018 ident: bib25 article-title: Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communities publication-title: Eur Respir J – volume: 54 year: 2019 ident: bib12 article-title: Unmasking the hidden tuberculosis mortality burden in a large publication-title: Eur Respir J – volume: 8 year: 2022 ident: bib34 article-title: Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa publication-title: Microb Genom – volume: 19 start-page: 30 year: 2020 ident: bib113 article-title: The prevalence of depression among patients with tuberculosis: a systematic review and meta-analysis publication-title: Ann Gen Psychiatry – year: 2020 ident: bib61 article-title: Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis 27–29 October 2020 – volume: 20 start-page: 426 year: 2014 end-page: 433 ident: bib35 article-title: Minimal diversity of drug-resistant Mycobacterium tuberculosis strains, South Africa publication-title: Emerg Infect Dis – year: June 6, 2019 ident: bib99 article-title: Pretomanid Tablet 200mg. Meeting of the Antimicrobial Drugs Advisory Committee – volume: 8 start-page: e00812 year: 2017 end-page: e00817 ident: bib51 article-title: The New Xpert MTB/RIF Ultra: improving detection of publication-title: MBio – volume: 7 start-page: 328 year: 2007 end-page: 337 ident: bib30 article-title: Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development publication-title: Lancet Infect Dis – volume: 11 start-page: e1402 year: 2023 end-page: e1411 ident: bib125 article-title: Nutritional support for adult patients with microbiologically confirmed pulmonary tuberculosis: outcomes in a programmatic cohort nested within the RATIONS trial in Jharkhand, India publication-title: Lancet Glob Health – volume: 16 start-page: 209 year: 2012 end-page: 215 ident: bib116 article-title: Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa publication-title: Int J Tuberc Lung Dis – year: 2021 ident: bib49 article-title: WHO Operational Handbook on Tuberculosis. Module 3: rapid diagnostics for tuberculosis detection, 2021 update – year: 2021 ident: bib53 article-title: Information sheet: practical considerations for implementation of the Roche cobas MTB and cobas MTB-RIF/INH assays – volume: 105 start-page: 631 year: 2015 end-page: 634 ident: bib120 article-title: Patient support interventions to improve adherence to drug-resistant tuberculosis treatment: a counselling toolkit publication-title: S Afr Med J – volume: 64 start-page: e1 year: 2022 end-page: 11 ident: bib126 article-title: Implementing active surveillance for tuberculosis: the experiences of healthcare workers at four sites in two provinces in South Africa publication-title: S Afr Fam Pract (2004) – volume: 12 start-page: 388 year: 2013 end-page: 404 ident: bib76 article-title: Advances in the development of new tuberculosis drugs and treatment regimens publication-title: Nat Rev Drug Discov – volume: 216 start-page: S644 year: 2017 end-page: S653 ident: bib28 article-title: Drivers of tuberculosis transmission publication-title: J Infect Dis – year: 2015 ident: bib115 article-title: The end TB strategy – volume: 9 start-page: 00182 year: 2023 end-page: 02023 ident: bib123 article-title: Evaluating the impact of cash transfers on tuberculosis (ExaCT TB): a stepped wedge cluster randomised controlled trial publication-title: ERJ Open Res – volume: 9 start-page: e479 year: 2021 end-page: e488 ident: bib102 article-title: Dynamic needs and challenges of people with drug-resistant tuberculosis and HIV in South Africa: a qualitative study publication-title: Lancet Glob Health – volume: 18 start-page: 24 year: 2020 ident: bib33 article-title: A landscape of genomic alterations at the root of a near-untreatable tuberculosis epidemic publication-title: BMC Med – volume: 32 start-page: 124 year: 2015 end-page: 127 ident: bib82 article-title: Perspectives on tuberculosis in pregnancy publication-title: Int J Infect Dis – volume: 53 year: 2019 ident: bib121 article-title: Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic review publication-title: Eur Respir J – volume: 3 year: 2023 ident: bib122 article-title: Experiences of conditional and unconditional cash transfers intended for improving health outcomes and health service use: a qualitative evidence synthesis publication-title: Cochrane Database Syst Rev – year: 2023 ident: bib58 article-title: Information sheet: practical considerations for implementation of the Nipro Genoscholar PZA-TB II assay – volume: 75 start-page: 2031 year: 2020 end-page: 2043 ident: bib68 article-title: Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid publication-title: J Antimicrob Chemother – volume: 24 start-page: 297 year: 2024 end-page: 307 ident: bib41 article-title: Emergence of bedaquiline-resistant tuberculosis and of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains with rpoB Ile491Phe mutation not detected by Xpert MTB/RIF in Mozambique: a retrospective observational study publication-title: Lancet Infect Dis – year: 2023 ident: bib63 article-title: Clinical management of rifampicin-resistant tuberculosis: updated clinical reference guide – volume: 55 start-page: 1532 year: 2012 end-page: 1549 ident: bib83 article-title: Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps publication-title: Clin Infect Dis – volume: 90 start-page: 325 year: 2022 end-page: 332 ident: bib137 article-title: Bedaquiline adherence measured by electronic dose monitoring predicts clinical outcomes in the treatment of patients with multidrug-resistant tuberculosis and HIV/AIDS publication-title: J Acquir Immune Defic Syndr – volume: 10 start-page: 388 year: 2004 end-page: 398 ident: bib59 article-title: Tuberculosis in HIV-infected patients: a comprehensive review publication-title: Clin Microbiol Infect – volume: 21 start-page: 852 year: 2017 end-page: 861 ident: bib114 article-title: Addressing the tuberculosis-depression syndemic to end the tuberculosis epidemic publication-title: Int J Tuberc Lung Dis – volume: 382 start-page: 893 year: 2020 end-page: 902 ident: bib77 article-title: Treatment of highly drug-resistant pulmonary tuberculosis publication-title: N Engl J Med – volume: 19 start-page: 1129 year: 2019 end-page: 1137 ident: bib130 article-title: Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis publication-title: Lancet Infect Dis – volume: 32 start-page: 68 year: 2015 end-page: 75 ident: bib103 article-title: Health status and quality of life in tuberculosis publication-title: Int J Infect Dis – year: 2023 ident: bib74 article-title: WHO standard: universal access to rapid tuberculosis diagnostics – volume: 387 start-page: 810 year: 2022 end-page: 823 ident: bib78 article-title: Bedaquiline-pretomanid-linezolid regimens for drug-resistant tuberculosis publication-title: N Engl J Med – volume: 368 start-page: 1575 year: 2006 end-page: 1580 ident: bib38 article-title: Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa publication-title: Lancet – volume: 22 start-page: 760 year: 2018 end-page: 765 ident: bib84 article-title: Burden of tuberculosis in HIV-positive pregnant women in Cape Town, South Africa publication-title: Int J Tuberc Lung Dis – volume: 60 year: 2023 ident: bib110 article-title: Drug-resistant tuberculosis stigma among healthcare workers toward the development of a stigma-reduction strategy: a scoping review publication-title: Inquiry – volume: 19 start-page: 1513 year: 2015 end-page: 1519 ident: bib105 article-title: Patients' costs associated with seeking and accessing treatment for drug-resistant tuberculosis in South Africa publication-title: Int J Tuberc Lung Dis – volume: 46 start-page: 279 year: 2014 end-page: 286 ident: bib19 article-title: Evolution and transmission of drug-resistant tuberculosis in a Russian population publication-title: Nat Genet – volume: 6 year: 2015 ident: bib21 article-title: Four decades of transmission of a multidrug-resistant Mycobacterium tuberculosis outbreak strain publication-title: Nat Commun – year: 2020 ident: bib62 article-title: Xpert MTB/RIF (English) (GeneXpert or Infinity System) Package Insert – volume: 46 start-page: 1 year: 2021 end-page: 24 ident: bib93 article-title: Clinical pharmacokinetics and pharmacodynamics of anti-tubercular drugs in pregnancy publication-title: Eur J Drug Metab Pharmacokinet – volume: 1 start-page: e165 year: 2020 end-page: e174 ident: bib43 article-title: Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis publication-title: Lancet Microbe – volume: 24 start-page: 776 year: 2023 ident: bib135 article-title: Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): study protocol for an adaptive randomized controlled trial publication-title: Trials – volume: 79 start-page: 3 year: 1998 end-page: 29 ident: bib22 article-title: Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update publication-title: Tuber Lung Dis – volume: 12 start-page: 104 year: 2020 ident: bib45 article-title: MDR publication-title: Genome Med – year: 2022 ident: bib17 article-title: National TB Recovery Plan Pretoria – volume: 22 start-page: 131 year: 2023 end-page: 135 ident: bib127 article-title: Community health workers can be trained to identify patients eligible for tuberculosis preventive therapy, but encounter barriers to programme implementation in KwaZulu-Natal, South Africa publication-title: Afr J AIDS Res – year: 2022 ident: bib56 article-title: Line probe assays for detection of drug-resistant tuberculosis – interpretation and reporting manual for laboratory staff and clinicians – volume: 59 year: 2022 ident: bib47 article-title: Emergence of bedaquiline resistance in a high tuberculosis burden country publication-title: Eur Respir J – volume: 12 year: 2017 ident: bib16 article-title: Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis publication-title: PLoS One – year: 2022 ident: bib64 article-title: WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update – volume: 9 start-page: e1372 year: 2021 end-page: e1379 ident: bib5 article-title: Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis publication-title: Lancet Glob Health – volume: 402 start-page: 627 year: 2023 end-page: 640 ident: bib124 article-title: Nutritional supplementation to prevent tuberculosis incidence in household contacts of patients with pulmonary tuberculosis in India (RATIONS): a field-based, open-label, cluster-randomised, controlled trial publication-title: Lancet – volume: 50 start-page: 995 year: 2012 end-page: 1002 ident: bib31 article-title: Population structure of multi- and extensively drug-resistant Mycobacterium tuberculosis strains in South Africa publication-title: J Clin Microbiol – reference: Cevik M, Eristavi M, Variava E, et al. SimpliciTB results and hepatic safety of pretomanid regimens +/- pyrazinamide. Seattle, WA, USA: Conference on retroviruses and oportunistic infections, 2023. – volume: 13 year: 2018 ident: bib32 article-title: Geospatial distribution of Mycobacterium tuberculosis genotypes in Africa publication-title: PLoS One – year: 2016 ident: bib55 article-title: Policy Update: the use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin – volume: 376 start-page: 243 year: 2017 end-page: 253 ident: bib24 article-title: Transmission of extensively drug-resistant tuberculosis in South Africa publication-title: N Engl J Med – year: 2019 ident: bib119 article-title: Multisectoral accountability framework to accelerate progress to end tuberculosis by 2030 – volume: 14 start-page: 21 year: 2016 ident: bib26 article-title: Interpreting whole genome sequencing for investigating tuberculosis transmission: a systematic review publication-title: BMC Med – year: 2022 ident: bib95 article-title: WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update – volume: 386 start-page: 93 year: 2022 end-page: 94 ident: bib69 article-title: Bedaquiline-resistant tuberculosis associated with publication-title: N Engl J Med – year: 2019 ident: bib111 article-title: Stop TB Partnership – volume: 20 start-page: 76 year: 2020 ident: bib109 article-title: “A very humiliating illness”: a qualitative study of patient-centered care for rifampicin-resistant tuberculosis in South Africa publication-title: BMC Public Health – volume: 15 start-page: 544 year: 2015 end-page: 551 ident: bib9 article-title: Burden of tuberculosis at post mortem in inpatients at a tertiary referral centre in sub-Saharan Africa: a prospective descriptive autopsy study publication-title: Lancet Infect Dis – volume: 387 start-page: 2331 year: 2022 end-page: 2343 ident: bib79 article-title: A 24-week, all-oral regimen for rifampin-resistant tuberculosis publication-title: N Engl J Med – volume: 98 start-page: 306 year: 2020 end-page: 314 ident: bib107 article-title: Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial publication-title: Bull World Health Organ – volume: 11 year: 2016 ident: bib100 article-title: Psycho-socio-economic issues challenging multidrug resistant tuberculosis patients: a systematic review publication-title: PLoS One – volume: 18 start-page: 1347 year: 2014 end-page: 1352 ident: bib129 article-title: Longevity loss among cured tuberculosis patients and the potential value of prevention publication-title: Int J Tuberc Lung Dis – volume: 5 start-page: e164 year: 2024 end-page: e172 ident: bib71 article-title: Opportunities and limitations of genomics for diagnosing bedaquiline-resistant tuberculosis: a systematic review and individual isolate meta-analysis publication-title: Lancet Microbe – year: 2022 ident: bib75 article-title: In vitro diagnostic medical devices used for the qualitative detection of Mycobacterium tuberculosis complex DNA and mutations associated with drug-resistant tuberculosis – volume: 14 year: 2023 ident: bib15 article-title: Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis publication-title: Nat Commun – volume: 68 start-page: 643 year: 2014 end-page: 652 ident: bib91 article-title: Body composition changes in pregnancy: measurement, predictors and outcomes publication-title: Eur J Clin Nutr – volume: 29 start-page: 1987 year: 2015 end-page: 2002 ident: bib10 article-title: Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis publication-title: AIDS – volume: 116 start-page: 23284 year: 2019 end-page: 23291 ident: bib18 article-title: Pre-detection history of extensively drug-resistant tuberculosis in KwaZulu-Natal, South Africa publication-title: Proc Natl Acad Sci USA – volume: 4 start-page: e972 year: 2023 end-page: e982 ident: bib65 article-title: Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study publication-title: Lancet Microbe – volume: 57 year: 2023 ident: bib133 article-title: Prevalence of long-term physical sequelae among patients treated with multi-drug and extensively drug-resistant tuberculosis: a systematic review and meta-analysis publication-title: EClinicalMedicine – volume: 3 year: 2023 ident: bib118 article-title: A scoping review of patient-centred tuberculosis care interventions: gaps and opportunities publication-title: PLoS Glob Public Health – year: 2023 ident: bib1 article-title: Global Tuberculosis Report 2023 – year: 2023 ident: bib50 article-title: Use of targeted next-generation sequencing to detect drug-resistant tuberculosis: rapid communication, July 2023 – year: 2023 ident: bib72 article-title: Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance – volume: 22 start-page: 496 year: 2022 end-page: 506 ident: bib42 article-title: Epidemiology, genetic basis and outcomes of bedaquiline resistant tuberculosis in South Africa: 2015–2019 publication-title: Lancet Infect Dis – year: 2016 ident: bib57 article-title: Policy Guidance: the use of molecular line probe assays for the detection of resistance to second-line anti-tuberculosis drugs – volume: 8 year: 2023 ident: bib73 article-title: Achieving universal access to rapid tuberculosis diagnostics publication-title: BMJ Glob Health – volume: 96 start-page: 33 year: 2000 end-page: 37 ident: bib90 article-title: Anthropometric estimation of maternal body composition in late gestation publication-title: Obstet Gynecol – volume: 18 start-page: 1350 year: 2018 end-page: 1359 ident: bib44 article-title: Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study publication-title: Lancet Infect Dis – volume: 66 start-page: 921 year: 2018 end-page: 929 ident: bib85 article-title: Poor obstetric and infant outcomes in human immunodeficiency virus-infected pregnant women with tuberculosis in South Africa: the tshepiso study publication-title: Clin Infect Dis – volume: 20 start-page: 430 year: 2016 end-page: 434 ident: bib117 article-title: Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV publication-title: Int J Tuberc Lung Dis – volume: 11 start-page: 139 year: 2021 end-page: 145 ident: bib101 article-title: Risk factors for poor engagement in drug-resistant TB care in South Africa: a systematic review publication-title: Public Health Action – year: 2018 ident: bib40 article-title: National Institute of Allergy and Infectious Diseases – year: 2016 ident: bib134 article-title: Differentiated care for HIV: a decision framework for antiretroviral therapy delivery – volume: 51 year: 2018 ident: bib139 article-title: The impact of digital health technologies on tuberculosis treatment: a systematic review publication-title: Eur Respir J – volume: 21 start-page: 488 year: 2021 ident: bib106 article-title: Socio-economic drivers of drug-resistant tuberculosis in Africa: a scoping review publication-title: BMC Public Health – reference: Ahmed S. Treament of children and adolescents using bedquiline and delaminid: results from the endTB study (OA24–764–21). Union World Conference on Lung Health, 2022. – year: 2023 ident: bib14 article-title: National Strategic Plan for HIV, TB and STIs, 2023–2028 – volume: 3 year: 2023 ident: bib66 article-title: Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanid publication-title: PLoS Glob Public Health – year: 2023 ident: bib54 article-title: Information sheet: practical considerations for implementation of the BD MAX MDR-TB test – volume: 22 start-page: 1172 year: 2022 end-page: 1180 ident: bib8 article-title: Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017–19: a multistage, cluster-based, cross-sectional survey publication-title: Lancet Infect Dis – volume: 12 start-page: 686 year: 2012 end-page: 694 ident: bib23 article-title: Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa publication-title: Infect Genet Evol – volume: 203 start-page: 358 year: 2011 end-page: 363 ident: bib88 article-title: Maternal tuberculosis: a risk factor for mother-to-child transmission of human immunodeficiency virus publication-title: J Infect Dis – volume: 16 year: 2019 ident: bib89 article-title: Inclusion of key populations in clinical trials of new antituberculosis treatments: current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons publication-title: PLoS Med – volume: 2 year: 2022 ident: bib7 article-title: Assessment of facility-based tuberculosis data quality in an integrated HIV/TB database in three South African districts publication-title: PLoS Glob Public Health – year: 2023 ident: bib13 article-title: Global Tuberculosis Programme. Tuberculosis data – volume: 27 start-page: 1171 year: 2021 end-page: 1177 ident: bib36 article-title: Prisons as ecological drivers of fitness-compensated multidrug-resistant Mycobacterium tuberculosis publication-title: Nat Med – volume: 124 start-page: S75 year: 2022 end-page: S81 ident: bib11 article-title: Incidental tuberculosis in sudden, unexpected, and violent deaths in the community Lusaka, Zambia – a descriptive forensic post-mortem examination study publication-title: Int J Infect Dis – volume: 373 start-page: 1986 year: 2015 end-page: 1988 ident: bib46 article-title: Acquired resistance to bedaquiline and delamanid in therapy for tuberculosis publication-title: N Engl J Med – volume: 103 start-page: 1067 year: 2020 end-page: 1071 ident: bib112 article-title: Major depression and stigma among individuals with multidrug-resistant tuberculosis in South Africa publication-title: Am J Trop Med Hyg – volume: 19 start-page: 22 year: 2021 ident: bib128 article-title: An analysis of the services provided by community health workers within an urban district in South Africa: a key contribution towards universal access to care publication-title: Hum Resour Health – volume: 48 start-page: 34 year: 2020 ident: bib131 article-title: Obstructive lung disease and quality of life after cure of multi-drug-resistant tuberculosis in Uganda: a cross-sectional study publication-title: Trop Med Health – volume: 73 start-page: e1901 year: 2021 end-page: e1910 ident: bib136 article-title: Electronic dose monitoring identifies a high-risk subpopulation in the treatment of drug-resistant tuberculosis and human immunodeficiency virus publication-title: Clin Infect Dis – year: 2022 ident: bib4 article-title: Implementing the End TB strategy: the essentials, 2022 update – volume: 218 start-page: 1964 year: 2018 end-page: 1973 ident: bib39 article-title: Spatial patterns of extensively drug-resistant tuberculosis transmission in KwaZulu-Natal, South Africa publication-title: J Infect Dis – volume: 12 year: 2015 ident: bib20 article-title: Evolution of extensively drug-resistant tuberculosis over four decades: whole genome sequencing and dating analysis of Mycobacterium tuberculosis isolates from KwaZulu-Natal publication-title: PLoS Med – reference: Conradie F, Phillips P, Badat T, et al. High rate of successful outcomes treating RR-TB with a delamanid-bedaquiline regimen in BEAT Tuberculosis: an interim analysis. Union World Conference on Lung Health, 2022. – reference: Joseph L, Ismail F, Ismail NA, Omar SV. Prevalence of linezolid resistance and associated mutations amongst pre-XDR and XDR isolates requiring drug susceptibility testing at the South African National TB Reference Laboratory. Hyderabad, India: 50th Union World Conference on Lung Health, 2019. – volume: 33 year: 2023 ident: bib81 article-title: Clinical features, resistance patterns and treatment outcomes of drug-resistant extra-pulmonary tuberculosis: a scoping review publication-title: J Clin Tuberc Other Mycobact Dis – volume: 69 start-page: 1229 year: 2019 end-page: 1231 ident: bib48 article-title: Emergence of low-level delamanid and bedaquiline resistance during extremely drug-resistant tuberculosis treatment publication-title: Clin Infect Dis – volume: 9 start-page: 1107 year: 2014 end-page: 1116 ident: bib108 article-title: Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV co-infected patients in South Africa publication-title: Glob Public Health – volume: 83 start-page: 2595 year: 2017 end-page: 2598 ident: bib92 article-title: Free dug concentrations in pregnancy: bound to measure unbound? publication-title: Br J Clin Pharmacol – volume: 19 start-page: 455 year: 2022 end-page: 470 ident: bib87 article-title: Evidence for Implementation: management of TB in HIV and pregnancy publication-title: Curr HIV/AIDS Rep – volume: 4 start-page: e20 year: 2023 ident: bib3 article-title: WHO's Global Tuberculosis Report 2022 publication-title: Lancet Microbe – volume: 124 start-page: 727 year: 2017 end-page: 733 ident: bib86 article-title: Maternal and perinatal mortality and morbidity associated with tuberculosis during pregnancy and the postpartum period: a systematic review and meta-analysis publication-title: BJOG – volume: 72 start-page: 1158 year: 2021 end-page: 1168 ident: bib94 article-title: Maternal and infant outcomes among pregnant women treated for multidrug/rifampicin-resistant tuberculosis in South Africa publication-title: Clin Infect Dis – volume: 12 start-page: e201 year: 2024 end-page: e216 ident: bib140 article-title: The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis publication-title: Lancet Glob Health – volume: 5 start-page: 291 year: 2017 end-page: 360 ident: bib6 article-title: The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis publication-title: Lancet Respir Med – volume: 55 start-page: 183 year: 2016 end-page: 198 ident: bib52 article-title: Detection of isoniazid-, fluoroquinolone-, amikacin-, and kanamycin-resistant tuberculosis in an automated, multiplexed 10-color assay suitable for point-of-care use publication-title: J Clin Microbiol – volume: 27 start-page: 248 year: 2023 end-page: 283 ident: bib104 article-title: Post-TB health and wellbeing publication-title: Int J Tuberc Lung Dis – volume: 5 start-page: e164 year: 2024 ident: 10.1016/S1473-3099(24)00144-0_bib71 article-title: Opportunities and limitations of genomics for diagnosing bedaquiline-resistant tuberculosis: a systematic review and individual isolate meta-analysis publication-title: Lancet Microbe doi: 10.1016/S2666-5247(23)00317-8 – volume: 9 start-page: 1107 year: 2014 ident: 10.1016/S1473-3099(24)00144-0_bib108 article-title: Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV co-infected patients in South Africa publication-title: Glob Public Health doi: 10.1080/17441692.2014.934266 – year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib50 – volume: 75 start-page: 2031 year: 2020 ident: 10.1016/S1473-3099(24)00144-0_bib68 article-title: Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkaa136 – volume: 50 start-page: 995 year: 2012 ident: 10.1016/S1473-3099(24)00144-0_bib31 article-title: Population structure of multi- and extensively drug-resistant Mycobacterium tuberculosis strains in South Africa publication-title: J Clin Microbiol doi: 10.1128/JCM.05832-11 – volume: 27 start-page: 1171 year: 2021 ident: 10.1016/S1473-3099(24)00144-0_bib36 article-title: Prisons as ecological drivers of fitness-compensated multidrug-resistant Mycobacterium tuberculosis publication-title: Nat Med doi: 10.1038/s41591-021-01358-x – volume: 19 start-page: 1513 year: 2015 ident: 10.1016/S1473-3099(24)00144-0_bib105 article-title: Patients' costs associated with seeking and accessing treatment for drug-resistant tuberculosis in South Africa publication-title: Int J Tuberc Lung Dis doi: 10.5588/ijtld.15.0341 – volume: 32 start-page: 68 year: 2015 ident: 10.1016/S1473-3099(24)00144-0_bib103 article-title: Health status and quality of life in tuberculosis publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2014.12.045 – volume: 4 start-page: e20 year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib3 article-title: WHO's Global Tuberculosis Report 2022 publication-title: Lancet Microbe doi: 10.1016/S2666-5247(22)00359-7 – year: 2019 ident: 10.1016/S1473-3099(24)00144-0_bib119 – volume: 96 start-page: 33 year: 2000 ident: 10.1016/S1473-3099(24)00144-0_bib90 article-title: Anthropometric estimation of maternal body composition in late gestation publication-title: Obstet Gynecol doi: 10.1016/S0029-7844(00)00857-7 – volume: 49 start-page: 395 year: 2017 ident: 10.1016/S1473-3099(24)00144-0_bib27 article-title: Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance publication-title: Nat Genet doi: 10.1038/ng.3767 – volume: 3 year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib66 article-title: Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanid publication-title: PLoS Glob Public Health doi: 10.1371/journal.pgph.0002283 – volume: 19 start-page: 455 year: 2022 ident: 10.1016/S1473-3099(24)00144-0_bib87 article-title: Evidence for Implementation: management of TB in HIV and pregnancy publication-title: Curr HIV/AIDS Rep doi: 10.1007/s11904-022-00641-x – volume: 21 start-page: 852 year: 2017 ident: 10.1016/S1473-3099(24)00144-0_bib114 article-title: Addressing the tuberculosis-depression syndemic to end the tuberculosis epidemic publication-title: Int J Tuberc Lung Dis doi: 10.5588/ijtld.16.0584 – volume: 3 year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib118 article-title: A scoping review of patient-centred tuberculosis care interventions: gaps and opportunities publication-title: PLoS Glob Public Health doi: 10.1371/journal.pgph.0001357 – volume: 54 year: 2019 ident: 10.1016/S1473-3099(24)00144-0_bib12 article-title: Unmasking the hidden tuberculosis mortality burden in a large post mortem study in Maputo Central Hospital, Mozambique publication-title: Eur Respir J doi: 10.1183/13993003.00312-2019 – volume: 203 start-page: 358 year: 2011 ident: 10.1016/S1473-3099(24)00144-0_bib88 article-title: Maternal tuberculosis: a risk factor for mother-to-child transmission of human immunodeficiency virus publication-title: J Infect Dis doi: 10.1093/jinfdis/jiq064 – ident: 10.1016/S1473-3099(24)00144-0_bib80 – volume: 12 start-page: 686 year: 2012 ident: 10.1016/S1473-3099(24)00144-0_bib23 article-title: Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa publication-title: Infect Genet Evol doi: 10.1016/j.meegid.2011.07.019 – volume: 376 start-page: 243 year: 2017 ident: 10.1016/S1473-3099(24)00144-0_bib24 article-title: Transmission of extensively drug-resistant tuberculosis in South Africa publication-title: N Engl J Med doi: 10.1056/NEJMoa1604544 – volume: 9 start-page: e479 year: 2021 ident: 10.1016/S1473-3099(24)00144-0_bib102 article-title: Dynamic needs and challenges of people with drug-resistant tuberculosis and HIV in South Africa: a qualitative study publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(20)30548-9 – volume: 1 start-page: e165 year: 2020 ident: 10.1016/S1473-3099(24)00144-0_bib43 article-title: Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis publication-title: Lancet Microbe doi: 10.1016/S2666-5247(20)30031-8 – volume: 13 year: 2018 ident: 10.1016/S1473-3099(24)00144-0_bib32 article-title: Geospatial distribution of Mycobacterium tuberculosis genotypes in Africa publication-title: PLoS One doi: 10.1371/journal.pone.0200632 – volume: 32 start-page: 124 year: 2015 ident: 10.1016/S1473-3099(24)00144-0_bib82 article-title: Perspectives on tuberculosis in pregnancy publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2014.12.014 – volume: 216 start-page: S644 issue: suppl 6 year: 2017 ident: 10.1016/S1473-3099(24)00144-0_bib28 article-title: Drivers of tuberculosis transmission publication-title: J Infect Dis doi: 10.1093/infdis/jix354 – volume: 7 start-page: 328 year: 2007 ident: 10.1016/S1473-3099(24)00144-0_bib30 article-title: Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(07)70108-1 – ident: 10.1016/S1473-3099(24)00144-0_bib97 – volume: 218 start-page: 1964 year: 2018 ident: 10.1016/S1473-3099(24)00144-0_bib39 article-title: Spatial patterns of extensively drug-resistant tuberculosis transmission in KwaZulu-Natal, South Africa publication-title: J Infect Dis – volume: 6 year: 2015 ident: 10.1016/S1473-3099(24)00144-0_bib21 article-title: Four decades of transmission of a multidrug-resistant Mycobacterium tuberculosis outbreak strain publication-title: Nat Commun doi: 10.1038/ncomms8119 – volume: 66 start-page: 921 year: 2018 ident: 10.1016/S1473-3099(24)00144-0_bib85 article-title: Poor obstetric and infant outcomes in human immunodeficiency virus-infected pregnant women with tuberculosis in South Africa: the tshepiso study publication-title: Clin Infect Dis doi: 10.1093/cid/cix851 – year: 2022 ident: 10.1016/S1473-3099(24)00144-0_bib2 – volume: 11 start-page: 139 year: 2021 ident: 10.1016/S1473-3099(24)00144-0_bib101 article-title: Risk factors for poor engagement in drug-resistant TB care in South Africa: a systematic review publication-title: Public Health Action doi: 10.5588/pha.21.0007 – year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib54 – volume: 16 start-page: 209 year: 2012 ident: 10.1016/S1473-3099(24)00144-0_bib116 article-title: Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa publication-title: Int J Tuberc Lung Dis doi: 10.5588/ijtld.11.0401 – year: 2016 ident: 10.1016/S1473-3099(24)00144-0_bib55 – volume: 11 start-page: e1402 year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib125 article-title: Nutritional support for adult patients with microbiologically confirmed pulmonary tuberculosis: outcomes in a programmatic cohort nested within the RATIONS trial in Jharkhand, India publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(23)00324-8 – volume: 57 start-page: e02057 year: 2019 ident: 10.1016/S1473-3099(24)00144-0_bib60 article-title: Diagnostic accuracy of Stool Xpert MTB/RIF for detection of pulmonary tuberculosis in children: a systematic review and meta-analysis publication-title: J Clin Microbiol doi: 10.1128/JCM.02057-18 – volume: 19 start-page: 30 year: 2020 ident: 10.1016/S1473-3099(24)00144-0_bib113 article-title: The prevalence of depression among patients with tuberculosis: a systematic review and meta-analysis publication-title: Ann Gen Psychiatry doi: 10.1186/s12991-020-00281-8 – volume: 57 year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib133 article-title: Prevalence of long-term physical sequelae among patients treated with multi-drug and extensively drug-resistant tuberculosis: a systematic review and meta-analysis publication-title: EClinicalMedicine doi: 10.1016/j.eclinm.2023.101900 – volume: 22 start-page: 1172 year: 2022 ident: 10.1016/S1473-3099(24)00144-0_bib8 article-title: Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017–19: a multistage, cluster-based, cross-sectional survey publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(22)00149-9 – volume: 9 start-page: e1372 year: 2021 ident: 10.1016/S1473-3099(24)00144-0_bib5 article-title: Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(21)00299-0 – volume: 12 start-page: 104 year: 2020 ident: 10.1016/S1473-3099(24)00144-0_bib45 article-title: MDR M. tuberculosis outbreak clone in Eswatini missed by Xpert has elevated bedaquiline resistance dated to the pre-treatment era publication-title: Genome Med doi: 10.1186/s13073-020-00793-8 – volume: 8 year: 2022 ident: 10.1016/S1473-3099(24)00144-0_bib34 article-title: Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa publication-title: Microb Genom – volume: 382 start-page: 893 year: 2020 ident: 10.1016/S1473-3099(24)00144-0_bib77 article-title: Treatment of highly drug-resistant pulmonary tuberculosis publication-title: N Engl J Med doi: 10.1056/NEJMoa1901814 – volume: 46 start-page: 279 year: 2014 ident: 10.1016/S1473-3099(24)00144-0_bib19 article-title: Evolution and transmission of drug-resistant tuberculosis in a Russian population publication-title: Nat Genet doi: 10.1038/ng.2878 – volume: 18 start-page: 171 year: 2018 ident: 10.1016/S1473-3099(24)00144-0_bib138 article-title: Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa publication-title: BMC Infect Dis doi: 10.1186/s12879-018-3080-2 – volume: 22 start-page: 131 year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib127 article-title: Community health workers can be trained to identify patients eligible for tuberculosis preventive therapy, but encounter barriers to programme implementation in KwaZulu-Natal, South Africa publication-title: Afr J AIDS Res doi: 10.2989/16085906.2023.2213213 – volume: 22 start-page: 496 year: 2022 ident: 10.1016/S1473-3099(24)00144-0_bib42 article-title: Epidemiology, genetic basis and outcomes of bedaquiline resistant tuberculosis in South Africa: 2015–2019 publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(21)00470-9 – volume: 68 start-page: 643 year: 2014 ident: 10.1016/S1473-3099(24)00144-0_bib91 article-title: Body composition changes in pregnancy: measurement, predictors and outcomes publication-title: Eur J Clin Nutr doi: 10.1038/ejcn.2014.40 – volume: 3 year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib122 article-title: Experiences of conditional and unconditional cash transfers intended for improving health outcomes and health service use: a qualitative evidence synthesis publication-title: Cochrane Database Syst Rev – volume: 21 start-page: 488 year: 2021 ident: 10.1016/S1473-3099(24)00144-0_bib106 article-title: Socio-economic drivers of drug-resistant tuberculosis in Africa: a scoping review publication-title: BMC Public Health doi: 10.1186/s12889-021-10267-0 – volume: 124 start-page: S75 issue: suppl 1 year: 2022 ident: 10.1016/S1473-3099(24)00144-0_bib11 article-title: Incidental tuberculosis in sudden, unexpected, and violent deaths in the community Lusaka, Zambia – a descriptive forensic post-mortem examination study publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2022.03.005 – volume: 10 start-page: 388 year: 2004 ident: 10.1016/S1473-3099(24)00144-0_bib59 article-title: Tuberculosis in HIV-infected patients: a comprehensive review publication-title: Clin Microbiol Infect doi: 10.1111/j.1469-0691.2004.00758.x – volume: 387 start-page: 2331 year: 2022 ident: 10.1016/S1473-3099(24)00144-0_bib79 article-title: A 24-week, all-oral regimen for rifampin-resistant tuberculosis publication-title: N Engl J Med doi: 10.1056/NEJMoa2117166 – year: 2016 ident: 10.1016/S1473-3099(24)00144-0_bib57 – volume: 402 start-page: 627 year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib124 article-title: Nutritional supplementation to prevent tuberculosis incidence in household contacts of patients with pulmonary tuberculosis in India (RATIONS): a field-based, open-label, cluster-randomised, controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(23)01231-X – year: 2021 ident: 10.1016/S1473-3099(24)00144-0_bib49 – volume: 72 start-page: 1158 year: 2021 ident: 10.1016/S1473-3099(24)00144-0_bib94 article-title: Maternal and infant outcomes among pregnant women treated for multidrug/rifampicin-resistant tuberculosis in South Africa publication-title: Clin Infect Dis doi: 10.1093/cid/ciaa189 – ident: 10.1016/S1473-3099(24)00144-0_bib70 – volume: 53 year: 2019 ident: 10.1016/S1473-3099(24)00144-0_bib121 article-title: Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic review publication-title: Eur Respir J doi: 10.1183/13993003.01030-2018 – volume: 9 start-page: 00182 year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib123 article-title: Evaluating the impact of cash transfers on tuberculosis (ExaCT TB): a stepped wedge cluster randomised controlled trial publication-title: ERJ Open Res doi: 10.1183/23120541.00182-2023 – volume: 116 start-page: 23284 year: 2019 ident: 10.1016/S1473-3099(24)00144-0_bib18 article-title: Pre-detection history of extensively drug-resistant tuberculosis in KwaZulu-Natal, South Africa publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1906636116 – volume: 18 start-page: 24 year: 2020 ident: 10.1016/S1473-3099(24)00144-0_bib33 article-title: A landscape of genomic alterations at the root of a near-untreatable tuberculosis epidemic publication-title: BMC Med doi: 10.1186/s12916-019-1487-2 – volume: 105 start-page: 631 year: 2015 ident: 10.1016/S1473-3099(24)00144-0_bib120 article-title: Patient support interventions to improve adherence to drug-resistant tuberculosis treatment: a counselling toolkit publication-title: S Afr Med J doi: 10.7196/SAMJnew.7803 – year: 2021 ident: 10.1016/S1473-3099(24)00144-0_bib53 – volume: 69 start-page: 1229 year: 2019 ident: 10.1016/S1473-3099(24)00144-0_bib48 article-title: Emergence of low-level delamanid and bedaquiline resistance during extremely drug-resistant tuberculosis treatment publication-title: Clin Infect Dis doi: 10.1093/cid/ciz074 – volume: 12 start-page: e201 year: 2024 ident: 10.1016/S1473-3099(24)00144-0_bib140 article-title: The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(23)00539-9 – year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib58 – volume: 4 start-page: e972 year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib65 article-title: Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study publication-title: Lancet Microbe doi: 10.1016/S2666-5247(23)00172-6 – year: 2022 ident: 10.1016/S1473-3099(24)00144-0_bib95 – volume: 73 start-page: e1901 year: 2021 ident: 10.1016/S1473-3099(24)00144-0_bib136 article-title: Electronic dose monitoring identifies a high-risk subpopulation in the treatment of drug-resistant tuberculosis and human immunodeficiency virus publication-title: Clin Infect Dis doi: 10.1093/cid/ciaa1557 – volume: 17 start-page: 275 year: 2017 ident: 10.1016/S1473-3099(24)00144-0_bib29 article-title: Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(16)30418-2 – volume: 90 start-page: 325 year: 2022 ident: 10.1016/S1473-3099(24)00144-0_bib137 article-title: Bedaquiline adherence measured by electronic dose monitoring predicts clinical outcomes in the treatment of patients with multidrug-resistant tuberculosis and HIV/AIDS publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0000000000002940 – volume: 22 start-page: 760 year: 2018 ident: 10.1016/S1473-3099(24)00144-0_bib84 article-title: Burden of tuberculosis in HIV-positive pregnant women in Cape Town, South Africa publication-title: Int J Tuberc Lung Dis doi: 10.5588/ijtld.17.0448 – ident: 10.1016/S1473-3099(24)00144-0_bib98 – volume: 48 start-page: 34 year: 2020 ident: 10.1016/S1473-3099(24)00144-0_bib131 article-title: Obstructive lung disease and quality of life after cure of multi-drug-resistant tuberculosis in Uganda: a cross-sectional study publication-title: Trop Med Health doi: 10.1186/s41182-020-00221-y – volume: 33 year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib81 article-title: Clinical features, resistance patterns and treatment outcomes of drug-resistant extra-pulmonary tuberculosis: a scoping review publication-title: J Clin Tuberc Other Mycobact Dis – volume: 103 start-page: 1067 year: 2020 ident: 10.1016/S1473-3099(24)00144-0_bib112 article-title: Major depression and stigma among individuals with multidrug-resistant tuberculosis in South Africa publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.19-0426 – volume: 46 start-page: 1 year: 2021 ident: 10.1016/S1473-3099(24)00144-0_bib93 article-title: Clinical pharmacokinetics and pharmacodynamics of anti-tubercular drugs in pregnancy publication-title: Eur J Drug Metab Pharmacokinet doi: 10.1007/s13318-020-00657-x – year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib13 – volume: 20 start-page: 430 year: 2016 ident: 10.1016/S1473-3099(24)00144-0_bib117 article-title: Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV publication-title: Int J Tuberc Lung Dis doi: 10.5588/ijtld.15.0360 – volume: 55 start-page: 183 year: 2016 ident: 10.1016/S1473-3099(24)00144-0_bib52 article-title: Detection of isoniazid-, fluoroquinolone-, amikacin-, and kanamycin-resistant tuberculosis in an automated, multiplexed 10-color assay suitable for point-of-care use publication-title: J Clin Microbiol doi: 10.1128/JCM.01771-16 – volume: 62 year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib67 article-title: Baseline and treatment-emergent bedaquiline resistance in drug-resistant tuberculosis: a systematic review and meta-analysis publication-title: Eur Respir J doi: 10.1183/13993003.00639-2023 – volume: 19 start-page: 1129 year: 2019 ident: 10.1016/S1473-3099(24)00144-0_bib130 article-title: Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(19)30309-3 – volume: 52 year: 2018 ident: 10.1016/S1473-3099(24)00144-0_bib25 article-title: Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communities publication-title: Eur Respir J doi: 10.1183/13993003.00246-2018 – volume: 20 start-page: 426 year: 2014 ident: 10.1016/S1473-3099(24)00144-0_bib35 article-title: Minimal diversity of drug-resistant Mycobacterium tuberculosis strains, South Africa publication-title: Emerg Infect Dis doi: 10.3201/eid2003.131083 – volume: 8 start-page: e00812 year: 2017 ident: 10.1016/S1473-3099(24)00144-0_bib51 article-title: The New Xpert MTB/RIF Ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing publication-title: MBio doi: 10.1128/mBio.00812-17 – volume: 12 year: 2017 ident: 10.1016/S1473-3099(24)00144-0_bib16 article-title: Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis publication-title: PLoS One doi: 10.1371/journal.pone.0185105 – year: 2015 ident: 10.1016/S1473-3099(24)00144-0_bib115 – year: 2022 ident: 10.1016/S1473-3099(24)00144-0_bib56 – volume: 40 start-page: e191 year: 2021 ident: 10.1016/S1473-3099(24)00144-0_bib96 article-title: Outcomes of children born to pregnant women with drug-resistant tuberculosis treated with novel drugs in Khayelitsha, South Africa: a report of five patients publication-title: Pediatr Infect Dis J doi: 10.1097/INF.0000000000003069 – volume: 373 start-page: 1986 year: 2015 ident: 10.1016/S1473-3099(24)00144-0_bib46 article-title: Acquired resistance to bedaquiline and delamanid in therapy for tuberculosis publication-title: N Engl J Med doi: 10.1056/NEJMc1505196 – volume: 14 year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib15 article-title: Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis publication-title: Nat Commun doi: 10.1038/s41467-023-41937-9 – volume: 27 start-page: 248 year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib104 article-title: Post-TB health and wellbeing publication-title: Int J Tuberc Lung Dis doi: 10.5588/ijtld.22.0514 – volume: 8 year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib73 article-title: Achieving universal access to rapid tuberculosis diagnostics publication-title: BMJ Glob Health doi: 10.1136/bmjgh-2023-012666 – volume: 14 start-page: 21 year: 2016 ident: 10.1016/S1473-3099(24)00144-0_bib26 article-title: Interpreting whole genome sequencing for investigating tuberculosis transmission: a systematic review publication-title: BMC Med doi: 10.1186/s12916-016-0566-x – year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib63 – volume: 55 start-page: 1532 year: 2012 ident: 10.1016/S1473-3099(24)00144-0_bib83 article-title: Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps publication-title: Clin Infect Dis doi: 10.1093/cid/cis732 – volume: 59 year: 2022 ident: 10.1016/S1473-3099(24)00144-0_bib47 article-title: Emergence of bedaquiline resistance in a high tuberculosis burden country publication-title: Eur Respir J doi: 10.1183/13993003.00621-2021 – year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib72 – year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib1 – volume: 83 start-page: 2595 year: 2017 ident: 10.1016/S1473-3099(24)00144-0_bib92 article-title: Free dug concentrations in pregnancy: bound to measure unbound? publication-title: Br J Clin Pharmacol doi: 10.1111/bcp.13432 – volume: 7 start-page: 7 year: 2018 ident: 10.1016/S1473-3099(24)00144-0_bib37 article-title: Compensatory evolution drives multidrug-resistant tuberculosis in Central Asia publication-title: eLife doi: 10.7554/eLife.38200 – year: 2022 ident: 10.1016/S1473-3099(24)00144-0_bib4 – volume: 98 start-page: 306 year: 2020 ident: 10.1016/S1473-3099(24)00144-0_bib107 article-title: Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial publication-title: Bull World Health Organ doi: 10.2471/BLT.19.243584 – volume: 2 year: 2022 ident: 10.1016/S1473-3099(24)00144-0_bib7 article-title: Assessment of facility-based tuberculosis data quality in an integrated HIV/TB database in three South African districts publication-title: PLoS Glob Public Health doi: 10.1371/journal.pgph.0000312 – year: 2022 ident: 10.1016/S1473-3099(24)00144-0_bib75 – volume: 12 start-page: 388 year: 2013 ident: 10.1016/S1473-3099(24)00144-0_bib76 article-title: Advances in the development of new tuberculosis drugs and treatment regimens publication-title: Nat Rev Drug Discov doi: 10.1038/nrd4001 – volume: 18 start-page: 1350 year: 2018 ident: 10.1016/S1473-3099(24)00144-0_bib44 article-title: Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(18)30496-1 – year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib74 – volume: 18 start-page: 1347 year: 2014 ident: 10.1016/S1473-3099(24)00144-0_bib129 article-title: Longevity loss among cured tuberculosis patients and the potential value of prevention publication-title: Int J Tuberc Lung Dis doi: 10.5588/ijtld.14.0242 – volume: 29 start-page: 1987 year: 2015 ident: 10.1016/S1473-3099(24)00144-0_bib10 article-title: Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis publication-title: AIDS doi: 10.1097/QAD.0000000000000802 – year: 2022 ident: 10.1016/S1473-3099(24)00144-0_bib17 – volume: 11 year: 2016 ident: 10.1016/S1473-3099(24)00144-0_bib100 article-title: Psycho-socio-economic issues challenging multidrug resistant tuberculosis patients: a systematic review publication-title: PLoS One doi: 10.1371/journal.pone.0147397 – volume: 60 year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib110 article-title: Drug-resistant tuberculosis stigma among healthcare workers toward the development of a stigma-reduction strategy: a scoping review publication-title: Inquiry – volume: 19 start-page: 22 year: 2021 ident: 10.1016/S1473-3099(24)00144-0_bib128 article-title: An analysis of the services provided by community health workers within an urban district in South Africa: a key contribution towards universal access to care publication-title: Hum Resour Health doi: 10.1186/s12960-021-00565-4 – volume: 5 start-page: 291 year: 2017 ident: 10.1016/S1473-3099(24)00144-0_bib6 article-title: The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(17)30079-6 – year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib14 – volume: 386 start-page: 93 year: 2022 ident: 10.1016/S1473-3099(24)00144-0_bib69 article-title: Bedaquiline-resistant tuberculosis associated with Rv0678 mutations publication-title: N Engl J Med doi: 10.1056/NEJMc2103049 – volume: 387 start-page: 810 year: 2022 ident: 10.1016/S1473-3099(24)00144-0_bib78 article-title: Bedaquiline-pretomanid-linezolid regimens for drug-resistant tuberculosis publication-title: N Engl J Med doi: 10.1056/NEJMoa2119430 – year: 2022 ident: 10.1016/S1473-3099(24)00144-0_bib64 – volume: 20 start-page: 76 year: 2020 ident: 10.1016/S1473-3099(24)00144-0_bib109 article-title: “A very humiliating illness”: a qualitative study of patient-centered care for rifampicin-resistant tuberculosis in South Africa publication-title: BMC Public Health doi: 10.1186/s12889-019-8035-z – volume: 15 start-page: 544 year: 2015 ident: 10.1016/S1473-3099(24)00144-0_bib9 article-title: Burden of tuberculosis at post mortem in inpatients at a tertiary referral centre in sub-Saharan Africa: a prospective descriptive autopsy study publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(15)70058-7 – volume: 24 start-page: 297 year: 2024 ident: 10.1016/S1473-3099(24)00144-0_bib41 article-title: Emergence of bedaquiline-resistant tuberculosis and of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains with rpoB Ile491Phe mutation not detected by Xpert MTB/RIF in Mozambique: a retrospective observational study publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(23)00498-X – year: 2020 ident: 10.1016/S1473-3099(24)00144-0_bib61 – volume: 368 start-page: 1575 year: 2006 ident: 10.1016/S1473-3099(24)00144-0_bib38 article-title: Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa publication-title: Lancet doi: 10.1016/S0140-6736(06)69573-1 – volume: 24 start-page: 776 year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib135 article-title: Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): study protocol for an adaptive randomized controlled trial publication-title: Trials doi: 10.1186/s13063-023-07520-9 – volume: 51 year: 2018 ident: 10.1016/S1473-3099(24)00144-0_bib139 article-title: The impact of digital health technologies on tuberculosis treatment: a systematic review publication-title: Eur Respir J doi: 10.1183/13993003.01596-2017 – volume: 16 year: 2019 ident: 10.1016/S1473-3099(24)00144-0_bib89 article-title: Inclusion of key populations in clinical trials of new antituberculosis treatments: current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons publication-title: PLoS Med doi: 10.1371/journal.pmed.1002882 – volume: 64 start-page: e1 year: 2022 ident: 10.1016/S1473-3099(24)00144-0_bib126 article-title: Implementing active surveillance for tuberculosis: the experiences of healthcare workers at four sites in two provinces in South Africa publication-title: S Afr Fam Pract (2004) – volume: 79 start-page: 3 year: 1998 ident: 10.1016/S1473-3099(24)00144-0_bib22 article-title: Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update publication-title: Tuber Lung Dis doi: 10.1054/tuld.1998.0002 – volume: 32 year: 2023 ident: 10.1016/S1473-3099(24)00144-0_bib132 article-title: Post-tuberculosis lung impairment: systematic review and meta-analysis of spirometry data from 14 621 people publication-title: Eur Respir Rev doi: 10.1183/16000617.0221-2022 – volume: 124 start-page: 727 year: 2017 ident: 10.1016/S1473-3099(24)00144-0_bib86 article-title: Maternal and perinatal mortality and morbidity associated with tuberculosis during pregnancy and the postpartum period: a systematic review and meta-analysis publication-title: BJOG doi: 10.1111/1471-0528.14408 – volume: 12 year: 2015 ident: 10.1016/S1473-3099(24)00144-0_bib20 article-title: Evolution of extensively drug-resistant tuberculosis over four decades: whole genome sequencing and dating analysis of Mycobacterium tuberculosis isolates from KwaZulu-Natal publication-title: PLoS Med doi: 10.1371/journal.pmed.1001880 |
| SSID | ssj0017104 |
| Score | 2.5330486 |
| SecondaryResourceType | review_article |
| Snippet | Drug-resistant tuberculosis (DR-TB) threatens to derail tuberculosis control efforts, particularly in Africa where the disease remains out of control. The... Summary Drug-resistant tuberculosis (DR-TB) threatens to derail tuberculosis control efforts, particularly in Africa where the disease remains out of control.... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e559 |
| SubjectTerms | Antitubercular Agents - therapeutic use COVID-19 Disease control Disease resistance Disease transmission Drug resistance Epidemics Epidemiology Humans Innovations Medical diagnosis Medical innovations Mycobacterium tuberculosis - drug effects Pandemics Patients Poverty Quality of life South Africa - epidemiology Tuberculosis Tuberculosis, Multidrug-Resistant - diagnosis Tuberculosis, Multidrug-Resistant - drug therapy Tuberculosis, Multidrug-Resistant - epidemiology Tuberculosis, Multidrug-Resistant - transmission |
| Title | The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis—lessons from the South African experience |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1473309924001440 https://dx.doi.org/10.1016/S1473-3099(24)00144-0 https://www.ncbi.nlm.nih.gov/pubmed/38527475 https://www.proquest.com/docview/3095398015 https://www.proquest.com/docview/3096558676 |
| Volume | 24 |
| WOSCitedRecordID | wos001306456200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1474-4457 dateEnd: 20251008 omitProxy: false ssIdentifier: ssj0017104 issn: 1473-3099 databaseCode: 7X7 dateStart: 20010801 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1474-4457 dateEnd: 20251008 omitProxy: false ssIdentifier: ssj0017104 issn: 1473-3099 databaseCode: 7RV dateStart: 20010801 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1474-4457 dateEnd: 20251008 omitProxy: false ssIdentifier: ssj0017104 issn: 1473-3099 databaseCode: BENPR dateStart: 20010801 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1474-4457 dateEnd: 20251008 omitProxy: false ssIdentifier: ssj0017104 issn: 1473-3099 databaseCode: 8C1 dateStart: 20010801 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JbtRAEC2RBCEkxBK2gTBqJA4gjRMv7e72CUGUiAOMorBobi33YhRp8IQZG4kbBz6BL-RLqHJ7PKcQJC59sF2WrXpdW9cC8CxViTeoiSKnhIo4p5a3XmVRqspYVia2SSgUfiunUzWbFSd9wG3Vp1WuZWInqN3CUoz8IKPGaAXK0_zl-deIpkbR6Wo_QmMLdpI05rQx1eGQ4pGg9uxOlbnMIqQvNhU8B--Hi89T_oIcBR7FF-mmi2zPTgcd3_rfr78NN3vrk70KcLkDV3y9C9fe9efru3AjRPFYKE66Cz8RRcxvhsh-n7CGlBuCg6JsE-ZCpt7ZasLK2rEvQzINW1TMLdvPEbrzZKLilaY1fmnbOT3--8evOcpYhDyjAheGZijrpvmxMLioZn7owXwPPh4ffTh8E_VzGyLLuWyQz9KYwnmXCetKZyqDHrtwhUuSght0aGxaJlakcVla0_l8lauUNYmXwpIIug_b9aL2D4FV1hY2k9TFrOIKqSupTOJkWQpEVGpGwNcc07Zvak6zNeZ6yF4jRmtitE657hit4xHsD2TnoavHZQRiDQe9LllFIatR71xGqAbC3qYJtsq_kO6tsaR7wbLSGyCN4OlwG7lO5zxl7Rdt94zIcyWkGMGDgNfhLzOVUxwif_T3lz-G6ylabyGZbg-2m2Xrn8BV-605Wy3HsCVPP9E6k92qxt2-G8PO66PpyekfCrkwUg |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VggAJ8SivhQJGAgmkDU2cl3NACBWqVt2ukChSbyZ-BFVasmWTgHrjwE_gd_Cj-CXMxEn2VMqlB66Ox3Lsbzwz9jwAnnARWIWSyDMiEV4UUcpbK0KPi9xPC-XrwAUKT9LpVBwcZO9W4FcfC0Nulf2Z2B7UZq7pjnwjpMRoGZ6n8aujLx5VjaLX1b6EhoPFrj3-hiZb9XLnDe7vU8633u5vbntdVQFPR1Fa4yxSpTJjTZhokxtVKLQnE5OZAO15heq25nmgE-7nuVatRVKYQmgV2DTRxCA47jk4T5nsyNgTm4NLSYDSun3FjtLQw_lmy4ihjfdD4zMePSfDJPL8k2ThSbpuK_O2rv1vq3UdrnbaNXvt2OEGrNhyDS7udf4Da3DF3VIyF3x1E34glzC7LJJ7PGY1CW8EP90ijplxnoiH1ZjlpWGfB2chNi-YWTSfvIWtSAXHlrpRdqGbGXX__f3nDGUIsjSjAB6GajZrqxUyV5ipZHbIMX0LPpzJmtyG1XJe2rvACq0zHaaUpa2IBFIXqVCBSfM8QY7hagRRjxCpu6TtVDtkJgfvPAKWJGBJHskWWNIfwYuB7MhlLTmNIOnhJ_uQXBQiEuXqaYRiIOx0NqeL_Qvpeo9d2R2clVwCdwSPh8-46_SOlZd23rR9kjgWSZqM4I7jj-EvQxHTPUt87--DP4JL2_t7EznZme7eh8scNVXnOLgOq_WisQ_ggv5aH1aLhy2HM_h41kzyB_EGjEI |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgqpKiEd5LRQwEkhU2rCJ87BzQAi1rKhaVpUAqTcTP1JVWrIlD1BvHPgJ_Bp-Dr-EcZxkT6VceuCaZCwn-T7PjD0PgKeUB0aiJvI0T7gXRbbkreGhR3nms1z6KnCJwvtsNuOHh-nBCvzqc2FsWGW_JrYLtV4ou0c-CW1htBTX03iSd2ERBzvTVydfPNtByp609u00HET2zOk3dN-ql7s7-K-fUTp982H7rdd1GPBUFLEaZ8SkTLXRYaJ0pmUu0bdMdKoD9O0lmt6KZoFKqJ9lSrbeSa5zrmRgWKIsWXDcS3CZhYhim6W-PYSXBKi52xPtiIUezj1dZg9N3g8Xn9NoyzopkeefpRfPsntb_Te9_j9_uRtwrbO6yWtHk5uwYooNWHvXxRVswFW3e0lcUtYt-IHsIWbZPPd0TGqr1JEUdndxTLSLUDyuxiQrNPk8BBGRRU502Rx5pamsaY5X6kaaUjVz-_jv7z_nqFuQ6sQm9hA0v0nbxZC4hk0FMUPt6dvw8UK-yR1YLRaFuQckVypVIbPV2_KIo3TOuAw0y7IEmUTlCKIeLUJ1xdxtT5G5GKL2LMiEBZmgkWhBJvwRvBjETlw1k_MEkh6Kok_VReUiUN-eJ8gHwc6Wczbav4hu9jgW3YJaiSWIR_BkuI1_3Z5vZYVZNO0zSRzzhCUjuOu4MrxlyGO7_xLf__vgj2ENuSH2d2d7D2CdogHr4gk3YbUuG_MQrqiv9XFVPmrJTuDTRXPkD_FclQc |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+epidemiology%2C+transmission%2C+diagnosis%2C+and+management+of+drug-resistant+tuberculosis%E2%80%94lessons+from+the+South+African+experience&rft.jtitle=The+Lancet+infectious+diseases&rft.au=Naidoo%2C+Kogieleum&rft.au=Perumal%2C+Rubeshan&rft.au=Cox%2C+Helen&rft.au=Mathema%2C+Barun&rft.date=2024-09-01&rft.pub=Elsevier+Ltd&rft.issn=1473-3099&rft.volume=24&rft.issue=9&rft.spage=e559&rft.epage=e575&rft_id=info:doi/10.1016%2FS1473-3099%2824%2900144-0&rft.externalDocID=S1473309924001440 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1473-3099&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1473-3099&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1473-3099&client=summon |